Advertisement

Topics

FDA approves Solco Healthcare’s Cymbalta generic

12:43 EDT 24 Aug 2017 | Drug Store News

The product had brand and generic sales of roughly $484.4 million for the 12 months ended June 2017, according to QuintilesIMS data.

read more

Original Article: FDA approves Solco Healthcare’s Cymbalta generic

NEXT ARTICLE

More From BioPortfolio on "FDA approves Solco Healthcare’s Cymbalta generic"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Story